查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442837

下一代定序儀市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

下一代定序儀 (NGS) 市場 - 報告範圍

TMR 關於全球下一代定序儀(NGS) 市場的報告研究了過去以及當前的成長趨勢和機會，以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球下一代定序儀( NGS) 市場的收入2017-2031 年下一代定序儀 (NGS) 市場，以 2023 年為基準年，2031 年為預測年。報告中也提供了2023年至2031年全球下一代定序儀（NGS）市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解下一代定序儀 (NGS) 市場。

該報告深入探討了全球下一代定序儀（NGS）市場的競爭格局。全球下一代定序儀 (NGS) 市場的主要參與者已經確定，每個參與者的各種屬性均已被描述。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球下一代定序儀 (NGS) 市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 監管場景
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按產品，2017-2031
    • 桌上型定序儀
    • 落地式音序器
  • 市場吸引力分析：按產品

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 腫瘤學
    • 傳染性疾病
    • 生殖健康
    • 宏基因組學、流行病學和藥物開發
    • 消費者基因體學
  • 市場吸引力分析：按應用

第 8 章：全球市場分析與預測：依技術分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2017-2031
    • 全基因組定序
    • 全外顯子定序
    • 標靶定序和重定序
  • 市場吸引力分析：依技術分類

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 學術研究
    • 臨床研究
    • 醫院和診所
    • 製藥和生物技術實體
    • 其他
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Pacific Biosciences
    • Complete Genomics Incorporated
    • Vela Diagnostics
    • Oxford Nanopore Technologies plc.
    • Singular Genomics Systems, Inc.
    • HTG Molecular Diagnostics, Inc.
    • Revvity
Product Code: TMRGL574

Next Generation Sequencers (NGS) Market - Scope of Report

TMR's report on the global next generation sequencers (NGS) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global next generation sequencers (NGS) market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global next generation sequencers (NGS) market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the next generation sequencers (NGS) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global next generation sequencers (NGS) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global next generation sequencers (NGS) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global next generation sequencers (NGS) market.

The report delves into the competitive landscape of the global next generation sequencers (NGS) market. Key players operating in the global next generation sequencers (NGS) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global next generation sequencers (NGS) market profiled in this report.

Key Questions Answered in Global next generation sequencers (NGS) Market Report:

  • What is the sales/revenue generated by next generation sequencers (NGS) across all regions during the forecast period?
  • What are the opportunities in the global next generation sequencers (NGS) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Next Generation Sequencers (NGS) Market - Research Objectives and Research Approach

The comprehensive report on the global next generation sequencers (NGS) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global next generation sequencers (NGS) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global next generation sequencers (NGS) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Next Generation Sequencers (NGS) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Benchtop Sequencers
    • 6.3.2. Floor Standing Sequencers
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Oncology
    • 7.3.2. Infectious Diseases
    • 7.3.3. Reproductive Health
    • 7.3.4. Metagenomics, Epidemiology, and Drug Development
    • 7.3.5. Consumer Genomics
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Technology, 2017-2031
    • 8.3.1. WGS
    • 8.3.2. Whole Exome Sequencing
    • 8.3.3. Targeted Sequencing & Resequencing
  • 8.4. Market Attractiveness Analysis, by Technology

9. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Academic Research
    • 9.3.2. Clinical Research
    • 9.3.3. Hospitals & Clinics
    • 9.3.4. Pharma & Biotech Entities
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Next Generation Sequencers (NGS) Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Next Generation Sequencers (NGS) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Benchtop Sequencers
    • 11.2.2. Floor Standing Sequencers
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Oncology
    • 11.3.2. Infectious Diseases
    • 11.3.3. Reproductive Health
    • 11.3.4. Metagenomics, Epidemiology, and Drug Development
    • 11.3.5. Consumer Genomics
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. WGS
    • 11.4.2. Whole Exome Sequencing
    • 11.4.3. Targeted Sequencing & Resequencing
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Academic Research
    • 11.5.2. Clinical Research
    • 11.5.3. Hospitals & Clinics
    • 11.5.4. Pharma & Biotech Entities
    • 11.5.5. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By Technology
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Next Generation Sequencers (NGS) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Benchtop Sequencers
    • 12.2.2. Floor Standing Sequencers
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Oncology
    • 12.3.2. Infectious Diseases
    • 12.3.3. Reproductive Health
    • 12.3.4. Metagenomics, Epidemiology, and Drug Development
    • 12.3.5. Consumer Genomics
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. WGS
    • 12.4.2. Whole Exome Sequencing
    • 12.4.3. Targeted Sequencing & Resequencing
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Academic Research
    • 12.5.2. Clinical Research
    • 12.5.3. Hospitals & Clinics
    • 12.5.4. Pharma & Biotech Entities
    • 12.5.5. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By Technology
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Next Generation Sequencers (NGS) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Benchtop Sequencers
    • 13.2.2. Floor Standing Sequencers
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Oncology
    • 13.3.2. Infectious Diseases
    • 13.3.3. Reproductive Health
    • 13.3.4. Metagenomics, Epidemiology, and Drug Development
    • 13.3.5. Consumer Genomics
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. WGS
    • 13.4.2. Whole Exome Sequencing
    • 13.4.3. Targeted Sequencing & Resequencing
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Academic Research
    • 13.5.2. Clinical Research
    • 13.5.3. Hospitals & Clinics
    • 13.5.4. Pharma & Biotech Entities
    • 13.5.5. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By Technology
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Next Generation Sequencers (NGS) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Benchtop Sequencers
    • 14.2.2. Floor Standing Sequencers
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Oncology
    • 14.3.2. Infectious Diseases
    • 14.3.3. Reproductive Health
    • 14.3.4. Metagenomics, Epidemiology, and Drug Development
    • 14.3.5. Consumer Genomics
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. WGS
    • 14.4.2. Whole Exome Sequencing
    • 14.4.3. Targeted Sequencing & Resequencing
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Academic Research
    • 14.5.2. Clinical Research
    • 14.5.3. Hospitals & Clinics
    • 14.5.4. Pharma & Biotech Entities
    • 14.5.5. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By Technology
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Next Generation Sequencers (NGS) Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Benchtop Sequencers
    • 15.2.2. Floor Standing Sequencers
  • 15.3. Market Value Forecast, by Application, 2017-2031
    • 15.3.1. Oncology
    • 15.3.2. Infectious Diseases
    • 15.3.3. Reproductive Health
    • 15.3.4. Metagenomics, Epidemiology, and Drug Development
    • 15.3.5. Consumer Genomics
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. WGS
    • 15.4.2. Whole Exome Sequencing
    • 15.4.3. Targeted Sequencing & Resequencing
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Academic Research
    • 15.5.2. Clinical Research
    • 15.5.3. Hospitals & Clinics
    • 15.5.4. Pharma & Biotech Entities
    • 15.5.5. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Application
    • 15.7.3. By Technology
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Illumina, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Pacific Biosciences
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Complete Genomics Incorporated
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Vela Diagnostics
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Oxford Nanopore Technologies plc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Singular Genomics Systems, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. HTG Molecular Diagnostics, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Revvity
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 04: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 15: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 20: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 25: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 30: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Next Generation Sequencers (NGS) Market Size, by Product, 2022
  • Figure 02: Global Next Generation Sequencers (NGS) Market Share (%), by Product, 2022
  • Figure 03: Global Next Generation Sequencers (NGS) Market Size, by Application, 2022
  • Figure 04: Global Next Generation Sequencers (NGS) Market Share (%), by Application, 2022
  • Figure 05: Global Next Generation Sequencers (NGS) Market Size, by Technology, 2022
  • Figure 06: Global Next Generation Sequencers (NGS) Market Share (%), by Technology, 2022
  • Figure 07: Global Next Generation Sequencers (NGS) Market Size, by End-user, 2022
  • Figure 08: Global Next Generation Sequencers (NGS) Market Share (%), by End-user, 2022
  • Figure 09: Global Next Generation Sequencers (NGS) Market, by Region (2022 and 2031)
  • Figure 10: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 12: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022
  • Figure 13: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2031
  • Figure 14: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 15: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 16: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022
  • Figure 17: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2031
  • Figure 18: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 19: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 20: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022
  • Figure 21: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2031
  • Figure 22: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 23: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022
  • Figure 25: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2031
  • Figure 26: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031
  • Figure 28: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2022
  • Figure 29: Global Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Region, 2031
  • Figure 30: Global Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 31: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: North America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 33: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 34: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 35: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 37: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-31
  • Figure 38: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 39: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-31
  • Figure 40: North America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 41: North America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 42: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 43: Europe Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 44: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 45: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 46: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 47: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 48: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 49: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 50: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 51: Europe Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Europe Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 53: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 54: Asia Pacific Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 55: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 57: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 58: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 59: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 60: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 61: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Asia Pacific Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 63: Asia Pacific Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 64: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 65: Latin America Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 66: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 68: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 69: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 70: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 71: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 72: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 73: Latin America Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 74: Latin America Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 75: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 76: Middle East & Africa Next Generation Sequencers (NGS) Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 77: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 78: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 79: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 80: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Application, 2022 and 2031
  • Figure 81: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 82: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by Technology, 2022 and 2031
  • Figure 83: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 84: Middle East & Africa Next Generation Sequencers (NGS) Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 85: Middle East & Africa Next Generation Sequencers (NGS) Market Attractiveness Analysis, by End-user, 2023-2031